No Data
No Data
Editas Medicine Maintains Hold Rating Amid Strategic Shifts and Financial Challenges
Walmart To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Friday
This Toll Brothers Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Express News | Editas Medicine Shares Are Trading Lower After Stifel and Chardan Capital Downgraded the Stock and Multiple Firms Cut Their Respective Price Targets
Express News | Barclays Maintains Equal-Weight on Editas Medicine, Lowers Price Target to $3
Chardan Capital Downgrades Editas Medicine to Neutral